Schedule 13G ownership disclosure

SURFACE ONCOLOGY INC

Security class unavailable · CUSIP: 86877M209

Event date: 2018-04-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,948,482
Percent of class
14.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-025863
Form type
SC 13G
Filer
Novartis Institutes for BioMedical Research, Inc.
CIK
CIK 1673852
Filed
Apr 23, 2018
Reporting period
Apr 18, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub